NCT02376608 - Bioavailability of Omega-3 Food Supplement in Healthy Subjects | Biotech Hunter

Enrollment

24

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions

Biological Availability

Interventions

DIETARY_SUPPLEMENT

Pronova Pure 150:500 EE EU

Each subject will participate in 4 treatment periods. The subjects are randomized to one of the following treatment sequences ABCD, BDAC, CADB, DCBA. 4 treatment free days between each treatment period

DIETARY_SUPPLEMENT

Pronovum PRF-037

Each subject will participate in 4 treatment periods. The subjects are randomized to one of the following treatment sequences ABCD, BDAC, CADB, DCBA. 4 treatment free days between each treatment period

DIETARY_SUPPLEMENT

Pronovum PRF-041

Each subject will participate in 4 treatment periods. The subjects are randomized to one of the following treatment sequences ABCD, BDAC, CADB, DCBA. 4 treatment free days between each treatment period

DIETARY_SUPPLEMENT

Eskimo-3

Each subject will participate in 4 treatment periods. The subjects are randomized to one of the following treatment sequences ABCD, BDAC, CADB, DCBA. 4 treatment free days between each treatment period

Trial Locations (1)

LS2 9LH

Covance Clinical research Unit (CRU) Ltd,Springfield House, Hyde street, Leeds